HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.

Abstract
Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia. However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels. Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt(-/-) pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1alpha expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.
AuthorsKeizo Kanasaki, Kristin Palmsten, Hikaru Sugimoto, Shakil Ahmad, Yuki Hamano, Liang Xie, Samuel Parry, Hellmut G Augustin, Vincent H Gattone, Judah Folkman, Jerome F Strauss, Raghu Kalluri
JournalNature (Nature) Vol. 453 Issue 7198 Pg. 1117-21 (Jun 19 2008) ISSN: 1476-4687 [Electronic] England
PMID18469803 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Estradiol
  • 2-Methoxyestradiol
  • Creatinine
  • Catechol O-Methyltransferase
  • Vascular Endothelial Growth Factor Receptor-1
Topics
  • 2-Methoxyestradiol
  • Albumins (analysis)
  • Animals
  • Blood Pressure
  • Catechol O-Methyltransferase (analysis, deficiency, genetics)
  • Creatinine (urine)
  • Disease Models, Animal
  • Estradiol (analogs & derivatives, blood, deficiency, urine)
  • Female
  • Humans
  • Hypertension
  • Hypoxia (metabolism)
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Killer Cells, Natural (immunology)
  • Litter Size
  • Male
  • Mice
  • Placenta (enzymology, pathology)
  • Pre-Eclampsia (blood, enzymology, metabolism, urine)
  • Pregnancy
  • Proteinuria
  • Vascular Endothelial Growth Factor Receptor-1 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: